[1] Park JI, Lee MG, Cho K, et al. Transforming growth factorβ1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38, NF-κB, JNK, and Ras signaling pathways[J]. Oncogene, 2003, 22(28): 4314-4332.
[2] Bergis D, Kassis V, Ranglack A, et al. High serum levels of the interleukin-33 receptor soluble ST2 as a negative prognostic factor in hepatocellular carcinoma[J]. Transl Oncol, 2013, 6(3): 311-318.
[3] Rafrafi A, Chahed B, Kaabachi S, et al. Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: a case control study[J]. Hum Immunol, 2013, 74(10): 1368-1374.
[4] Shimizu M, Saitoh Y, Itoh H. Immunohistochemical staining of Haras oncogene product in normal, benign, and malignant human pancrestic tissue[J]. Hum Pathol, 1990, 21(6): 607-612.
[5] 陈友康, 龚谋春. 胃癌根治术后血浆中细胞因子的变化及临床意义[J]. 实用临床医药杂志, 2009, 13(12): 105-106.
[6] 李冰, 陈凛. 癌组织中IL6、IL6R及PCNA的检测及临床意义[J]. 山东医药, 2008, 48(14): 1-2.
[7] 包怀鸣, 陈志荣. 血清IL6、IL8在胃癌中的表达及意义[J]. 中国煤炭工业医学杂志, 2008, 11(6): 838-839.
[8] 周春红, 蒋茜, 盛月华, 等. 胃癌患者血清TNF、IL2、IL6检测[J]. 齐齐哈尔医学院学报, 2009, 30(18): 2237-2238.
[9] Yae S, Takahashi F, Yae T, et al. Hochuekkito (TJ41), a Kampo formula, ameliorates cachexia induced by colon 26 adenocarcinoma in mice[J]. Evid Based Complement Alternat Med, 2012, 2012: 976926.
[10] Wu Y, Fan Y, Jiang Y, et al. Analysis of risk factors associated with precancerous lesion of gastric cancer in patients from eastern China: a comparative study[J]. J Cancer Res Ther, 2013, 9(2): 205-209.
[11] 王跃华, 江志伟, 汪志明. 胃癌恶病质病人机体组成与细胞因子的相关性研究[J]. 肠外与肠内营养, 2009, 16(5): 286-287. |